Biodiveristy, Ethics, and Human Health

This document summarizes the key points about biodiversity loss and its impacts on human health and medication development. It discusses how biodiversity provides benefits through natural products that have led to many current medications, especially antibiotics and anticancer drugs. Loss of biodiversity limits these benefits as it reduces available natural compounds for medication research and development. This can increase health risks by reducing effective treatments for diseases. The document calls for policies to preserve biodiversity and incentivize natural product research to maintain these health benefits for current and future generations.